Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the company’s application for bank credit with its own assets
Securities code: 603456 Securities abbreviation: Jiuzhou Pharmaceutical Announcement number: 2026-014
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Announcement on the company's application for bank credit with its own assets
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
On April 23, 2026, the 20th meeting of the eighth board of directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") reviewed and approved the "Proposal on the Company and its Subsidiaries Applying for Credit Lines from Banks in 2026" and the "Proposal on the Company and its Subsidiaries Providing Asset Mortgage for Applying for Credit Lines from Banks in 2026". The relevant matters are now announced as follows:
It is agreed that the company and its subsidiaries will use their land use rights and the properties on the relevant land to provide mortgage guarantees with a maximum mortgage amount of no more than 1.000 billion yuan for the company and its subsidiaries (guaranteed) to apply for a credit line of 4.85 billion yuan from 13 banks including Agricultural Bank of China Co., Ltd., Industrial and Commercial Bank of China Co., Ltd., and Bank of China Co., Ltd.
The credit limit is ultimately subject to the amount actually approved by each bank, and the specific financing amount will be determined based on the company's actual operating conditions. Within the credit period, the credit limit can be recycled. The board of directors authorizes the chairman of the company to sign or authorize others to sign relevant agreements, documents, etc. within the above-mentioned amount range according to business needs.
The above credit and authorization matters are valid from the date of review and approval by the company's 2025 annual shareholders' meeting to the date of the 2026 annual shareholders' meeting.
The company expects to apply for credit lines from various banks in 2026 as follows:
Unit: 10,000 yuan Currency: RMB Bank name Credit limit
Agricultural Bank of China Co., Ltd. 145,000.00
Industrial and Commercial Bank of China Co., Ltd. 135,000.00
Bank of China Co., Ltd. 45,000.00
China Construction Bank Co., Ltd. 30,000.00
Export-Import Bank of China 20,000.00
China Merchants Bank Co., Ltd. 20,000.00
Bank of Ningbo Co., Ltd. 20,000.00
China Everbright Bank Co., Ltd. 15,000.00
Bank of Communications Co., Ltd. 15,000.00 HSBC Bank (China) Co., Ltd. 10,000.00 Shanghai Pudong Development Bank Co., Ltd. 10,000.00
United Community Bank 10,000.00Standard Chartered Bank (China) Co., Ltd. 10,000.00
Total 485,000.00 Note: The credit limit in the above table is only an estimate made by the company based on the financing credit limit of the previous year. The actual credit limit
The final limit is subject to the actual credit limit approved by each credit-granting bank.
Announcement is hereby made.
Board of Directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
April 24, 2026